IPO registrations (S-1, F-1) · Registrants
Bone Biologics Corp
- SEC CIK
- 1419554 · filings on EDGAR ↗
- Former names
- Bone Biologics, Corp. (2014–2015); AFH ACQUISITION X, INC. (2008–2014)
- Registration
- Form S-1, first filed 2014-11-12, last 2025-06-24; 7 initial registrations, 11 amendments
- Outcome
- Final prospectus filed 2021-10-15; declared effective 2015-06-11
- Industry (SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies 3842
- Incorporated in
- DE
- Business address
- 2 BURLINGTON WOODS DRIVE,, SUITE 100,, Burlington, MA 01803
- EIN
- 42-1743430
- Ticker
- BBLG (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Bone Biologics Corp on the corporate pages
On this site
- Form D issuer: Bone Biologics Corp EXACT (CIK (EXACT))
- SEC filer: AFH ACQUISITION X, INC. EXACT (CIK (EXACT))
Filings 42
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-11-12 | S-1 | S-1 (registration) | Bone Biologics, Corp. | 0001493152-14-003664 ↗ |
| 2015-04-30 | S-1/A | S-1/A (amendment) | Bone Biologics, Corp. | 0001493152-15-001635 ↗ |
| 2015-05-28 | S-1/A | S-1/A (amendment) | Bone Biologics, Corp. | 0001493152-15-002273 ↗ |
| 2015-06-11 | EFFECT | EFFECT (declared effective) | Bone Biologics, Corp. | 9999999995-15-001600 ↗ |
| 2016-08-04 | S-1 | S-1 (registration) | Bone Biologics Corp | 0001493152-16-011959 ↗ |
| 2016-08-08 | EFFECT | EFFECT (declared effective) | Bone Biologics Corp | 9999999995-16-005386 ↗ |
| 2016-08-12 | EFFECT | EFFECT (declared effective) | Bone Biologics Corp | 9999999995-16-005436 ↗ |
| 2017-10-23 | EFFECT | EFFECT (declared effective) | Bone Biologics Corp | 9999999995-17-002747 ↗ |
| 2017-10-23 | EFFECT | EFFECT (declared effective) | Bone Biologics Corp | 9999999995-17-002748 ↗ |
| 2021-06-28 | S-1 | S-1 (registration) | Bone Biologics Corp | 0001493152-21-015404 ↗ |
| 2021-08-30 | S-1/A | S-1/A (amendment) | Bone Biologics Corp | 0001493152-21-021565 ↗ |
| 2021-10-06 | S-1/A | S-1/A (amendment) | Bone Biologics Corp | 0001493152-21-024833 ↗ |
| 2021-10-07 | S-1/A | S-1/A (amendment) | Bone Biologics Corp | 0001493152-21-024979 ↗ |
| 2021-10-12 | S-1MEF | S-1MEF (added securities) | Bone Biologics Corp | 0001493152-21-025249 ↗ |
| 2021-10-12 | EFFECT | EFFECT (declared effective) | Bone Biologics Corp | 9999999995-21-003847 ↗ |
| 2021-10-15 | 424B4 | 424B4 (final prospectus) | Bone Biologics Corp | 0001493152-21-025493 ↗ |
| 2021-10-15 | 424B4 | 424B4 (final prospectus) | Bone Biologics Corp | 0001493152-21-025495 ↗ |
| 2022-07-11 | EFFECT | EFFECT (declared effective) | Bone Biologics Corp | 9999999995-22-002014 ↗ |
| 2022-09-23 | S-1 | S-1 (registration) | Bone Biologics Corp | 0001493152-22-026702 ↗ |
| 2022-10-04 | S-1/A | S-1/A (amendment) | Bone Biologics Corp | 0001493152-22-027481 ↗ |
| 2022-10-05 | S-1/A | S-1/A (amendment) | Bone Biologics Corp | 0001493152-22-027628 ↗ |
| 2022-10-06 | EFFECT | EFFECT (declared effective) | Bone Biologics Corp | 9999999995-22-002973 ↗ |
| 2022-10-07 | S-1MEF | S-1MEF (added securities) | Bone Biologics Corp | 0001493152-22-027869 ↗ |
| 2022-10-07 | S-1MEF | S-1MEF (added securities) | Bone Biologics Corp | 0001493152-22-027877 ↗ |
| 2022-10-11 | 424B4 | 424B4 (final prospectus) | Bone Biologics Corp | 0001493152-22-028069 ↗ |
| 2023-05-01 | S-1 | S-1 (registration) | Bone Biologics Corp | 0001493152-23-015035 ↗ |
| 2023-06-06 | S-1/A | S-1/A (amendment) | Bone Biologics Corp | 0001493152-23-020316 ↗ |
| 2023-06-13 | S-1/A | S-1/A (amendment) | Bone Biologics Corp | 0001493152-23-020997 ↗ |
| 2023-06-14 | EFFECT | EFFECT (declared effective) | Bone Biologics Corp | 9999999995-23-001748 ↗ |
| 2023-06-16 | 424B4 | 424B4 (final prospectus) | Bone Biologics Corp | 0001493152-23-021533 ↗ |
| 2024-01-24 | EFFECT | EFFECT (declared effective) | Bone Biologics Corp | 9999999995-24-000199 ↗ |
| 2024-01-30 | S-1 | S-1 (registration) | Bone Biologics Corp | 0001493152-24-004349 ↗ |
| 2024-02-23 | S-1/A | S-1/A (amendment) | Bone Biologics Corp | 0001493152-24-007706 ↗ |
| 2024-02-26 | S-1/A | S-1/A (amendment) | Bone Biologics Corp | 0001493152-24-007837 ↗ |
| 2024-03-04 | 424B4 | 424B4 (final prospectus) | Bone Biologics Corp | 0001493152-24-008713 ↗ |
| 2024-03-04 | EFFECT | EFFECT (declared effective) | Bone Biologics Corp | 9999999995-24-000598 ↗ |
| 2024-08-26 | EFFECT | EFFECT (declared effective) | Bone Biologics Corp | 9999999995-24-002641 ↗ |
| 2025-06-24 | S-1 | S-1 (registration) | Bone Biologics Corp | 0001641172-25-016289 ↗ |
| 2025-06-27 | EFFECT | EFFECT (declared effective) | Bone Biologics Corp | 9999999995-25-002071 ↗ |
| 2025-06-30 | 424B4 | 424B4 (final prospectus) | Bone Biologics Corp | 0001641172-25-017063 ↗ |
| 2025-09-02 | EFFECT | EFFECT (declared effective) | Bone Biologics Corp | 9999999995-25-002798 ↗ |
| 2026-07-24 | EFFECT | EFFECT (declared effective) | Bone Biologics Corp | 9999999995-26-002449 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Heshmatpour Amir F | Director,Officer; Director,Officer,TenPercentOwner; TenPercentOwner | President and Secretary; President, Secretary | 4 | 2008–2015 | |
| AFH Holding & Advisory, LLC | TenPercentOwner | 13 | 2008–2017 | ||
| Hankey Investment Co LP | Director,Officer | CFO, President, Secretary | 1 | 2014 | |
| Frelick Jeff | Officer | Chief Executive Officer; Chief Operating Officer | 14 | 2015–2026 | |
| La Neve Stephen R. | Director,Officer; Officer | CEO and President; CEO & President | 7 | 2015–2018 | |
| Heshmatpour Amir F | Director; TenPercentOwner | 8 | 2015–2017 | ||
| Walsh Deina H | Officer | Chief Financial Officer | 13 | 2015–2026 | |
| Stroever Bruce | Director | 7 | 2015–2026 | ||
| Booth John J | Director | 7 | 2015–2019 | ||
| COFFIN WILLIAM F | Director | 3 | 2015 | ||
| Delshad Jim | Director | 5 | 2015–2018 | ||
| MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. | Director; TenPercentOwner | 3 | 2015–2016 | ||
| ORAM GEORGE A | Director | 2 | 2015 | ||
| SOO B CHIA | Director | 4 | 2015–2016 | ||
| WARNECKE STEVE B | Director | 4 | 2015–2016 | ||
| Treat William Jay | Officer | Chief Technology Officer | 3 | 2015–2016 | |
| WU BENJAMIN | Director | 4 | 2015–2016 | ||
| Hankey Bret | Director | 7 | 2018–2020 | ||
| Don Hankey Trust | Other; TenPercentOwner | 7 | 2018–2020 | ||
| HANKEY CAPITAL, LLC | TenPercentOwner | 8 | 2018–2021 | ||
| Hankey Don | Director,Officer,TenPercentOwner | Chairman of the Board | 9 | 2018–2023 | |
| Angle Siddhesh Rajendra | Director | 7 | 2021–2026 | ||
| Lucera Erick | Director | 4 | 2021–2023 | ||
| Knight Insurance Company, Ltd | TenPercentOwner | 1 | 2023 | ||
| Gagnon Robert E. | Director | 5 | 2024–2026 | ||
| Meikle Phillip Terry II | Director | 4 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2023-11-29 | Bone Biologics Corp | Biotechnology | $729,000 | $729,000 | 4 | 1 |
| 2018-07-23 | Bone Biologics Corp | Biotechnology | $5,869,979 | $5,869,979 | 4 | 1 |
| 2017-08-30 | Bone Biologics Corp | Biotechnology | $10,000,000 | $1,900,000 | 2 | 2 |
| 2016-03-23 | Bone Biologics Corp | Biotechnology | $4,500,000 | $0 | 3 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.